TREATMENT
Immunotherapy Compared to Standard Care in MSS Metastatic CRCA propensity-matched analysis of 708 chemorefractory patients compared immune checkpoint inhibitors to standard treatments like trifluridine/tipiracil in microsatellite stable metastatic colorectal cancer, though ICIs have limited efficacy in this population and selected patients with specific metastatic patterns may derive benefit. (Journal for ImmunoTherapy of Cancer)